A BILL 
To prohibit the Secretary of Health and Human Services 
from issuing guidance intended to restrict access to 
COVID–19 monoclonal antibody therapies and other 
treatments. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Equal Access to Thera-
4
peutics Act’’. 
5
00:34 Feb 10, 2022
H6625
dlhill on DSK120RN23PROD with BILLS
2 
•HR 6625 IH
SEC. 2. PROHIBITION ON RESTRICTIONS ON DIRECT AC-
1
CESS TO COVID–19 MONOCLONAL ANTIBODY 
2
THERAPIES. 
3
(a) IN GENERAL.—Notwithstanding any other provi-
4
sion of law, the Secretary of Health and Human Services 
5
may not issue, implement, or continue in effect any policy 
6
or guidance intended to base any determination on wheth-
7
er an individual may access COVID–19 monoclonal anti-
8
body therapies and other COVID–19 treatments on the 
9
race or ethnicity of such individual. 
10
(b) PENALTIES.—The Secretary of Health and 
11
Human Services shall be held personally liable for the 
12
death of any individual who is denied access to COVID– 
13
19 monoclonal antibody therapies and other treatments 
14
pursuant to any policy or guidance prohibited under sub-
15
section (a). 
16
SEC. 3. PROHIBITION ON FEDERAL FUNDING TO HOS-
17
PITALS AND HEALTH CARE PROVIDERS WHO 
18
RESTRICT 
ACCESS 
TO 
COVID–19 
19
MONOCLONAL ANTIBODY THERAPIES. 
20
No Federal funds may be disbursed to any hospital 
21
or other health care provider that has in effect a policy 
22
that restricts access by individuals to COVID–19 
23
monoclonal antibody therapies and other COVID–19 
24
00:26 Feb 10, 2022
H6625
dlhill on DSK120RN23PROD with BILLS
3 
•HR 6625 IH
treatments based on the race or ethnicity of such individ-
1
uals. 
2
Æ 
00:26 Feb 10, 2022
H6625
dlhill on DSK120RN23PROD with BILLS
